Shenzhen Lifotronic Technology (SHSE:688389) Is Experiencing Growth In Returns On Capital

What are the early trends we should look for to identify a stock that could multiply in value over the long term? Amongst other things, we'll want to see two things; firstly, a growing return on capital employed (ROCE) and secondly, an expansion in the company's amount of capital employed. Basically this means that a company has profitable initiatives that it can continue to reinvest in, which is a trait of a compounding machine. So when we looked at Shenzhen Lifotronic Technology (SHSE:688389) and its trend of ROCE, we really liked what we saw.

Understanding Return On Capital Employed (ROCE)

If you haven't worked with ROCE before, it measures the 'return' (pre-tax profit) a company generates from capital employed in its business. To calculate this metric for Shenzhen Lifotronic Technology, this is the formula:

Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)

0.18 = CN¥335m ÷ (CN¥2.4b - CN¥439m) (Based on the trailing twelve months to March 2024).

Therefore, Shenzhen Lifotronic Technology has an ROCE of 18%. On its own, that's a standard return, however it's much better than the 6.4% generated by the Medical Equipment industry.

Check out our latest analysis for Shenzhen Lifotronic Technology

Above you can see how the current ROCE for Shenzhen Lifotronic Technology compares to its prior returns on capital, but there's only so much you can tell from the past. If you'd like, you can check out the forecasts from the analysts covering Shenzhen Lifotronic Technology for free.

So How Is Shenzhen Lifotronic Technology's ROCE Trending?

Shenzhen Lifotronic Technology is displaying some positive trends. The numbers show that in the last five years, the returns generated on capital employed have grown considerably to 18%. The amount of capital employed has increased too, by 172%. So we're very much inspired by what we're seeing at Shenzhen Lifotronic Technology thanks to its ability to profitably reinvest capital.

The Key Takeaway

In summary, it's great to see that Shenzhen Lifotronic Technology can compound returns by consistently reinvesting capital at increasing rates of return, because these are some of the key ingredients of those highly sought after multi-baggers. Astute investors may have an opportunity here because the stock has declined 33% in the last three years. That being the case, research into the company's current valuation metrics and future prospects seems fitting.

On a separate note, we've found 1 warning sign for Shenzhen Lifotronic Technology you'll probably want to know about.

While Shenzhen Lifotronic Technology isn't earning the highest return, check out this free list of companies that are earning high returns on equity with solid balance sheets.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.